BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3037615)

  • 1. Disappearance of Tc-99m HMDP tumor uptake in oat cell carcinoma after irradiation and chemotherapy.
    Shih WJ; Domstad PA; DeLand FH
    Radiat Med; 1986; 4(4):107-9. PubMed ID: 3037615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ring appearance of Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small cell carcinoma.
    Shih WJ; Turturro F; Stipp V; DeSimone P
    Ann Nucl Med; 1996 Nov; 10(4):425-8. PubMed ID: 9006728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.
    Belhocine T; Steinmetz N; Hustinx R; Bartsch P; Jerusalem G; Seidel L; Rigo P; Green A
    Clin Cancer Res; 2002 Sep; 8(9):2766-74. PubMed ID: 12231515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer.
    Fukuchi K; Yamaguchi M; Hayashida K; Ishida Y
    Clin Nucl Med; 2003 Mar; 28(3):232-3. PubMed ID: 12592136
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient splenic accumulation of Tc-99m HMDP caused by megaloblastic anemia.
    Koizumi M; Suzuki T; Takahashi S; Ogata E
    Clin Nucl Med; 2000 Dec; 25(12):1024-7. PubMed ID: 11129139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of technetium-99m diphosphonate by metastatic large cell carcinoma of the lung.
    Marsh JI; Belzberg AS; Murphy KC
    J Nucl Med; 1988 May; 29(5):726-8. PubMed ID: 2836571
    [No Abstract]   [Full Text] [Related]  

  • 7. Intense uptake of Tc-99m HMDP in pleural metastasis from osteosarcoma.
    Biyi A; Doudouh A; Albouzidi A; Zekri A
    Clin Nucl Med; 2006 Jul; 31(7):423-4. PubMed ID: 16785816
    [No Abstract]   [Full Text] [Related]  

  • 8. Discrepant uptake between 111In-pentetreotide and 99mTc-MDP in bone metastases of small-cell lung cancer.
    Meristoudis G; Ilias I; Giannakopoulos V; Batsakis C; Christakopoulou J
    Hell J Nucl Med; 2009; 12(3):283-4. PubMed ID: 19936347
    [No Abstract]   [Full Text] [Related]  

  • 9. Ectopic accumulation of 99mTc-HMDP in primary lung cancer in comparison with CT findings.
    Yoshida S; Fukumoto M; Yoshimura N; Oobayashi K; Takada Y
    Ann Nucl Med; 1996 Aug; 10(3):329-33. PubMed ID: 8883709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal primary lymphoma of bone: scintigraphy and MR findings before and after treatment.
    Yuki M; Narabayashi I; Yamamoto K; Shimizu T; Tanaka Y; Tatsumi T; Komori T
    Radiat Med; 2000; 18(5):305-10. PubMed ID: 11128401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone agent localization in hepatic metastases.
    Shih WJ; Han JK; Magoun S; Wierzbinski B
    J Nucl Med Technol; 1999 Mar; 27(1):38-40. PubMed ID: 10322573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast.
    Ohta H; Yamamoto S; Ukikusa M; Awane H; Shintaku M; Irie K
    Clin Nucl Med; 1997 Aug; 22(8):553-4. PubMed ID: 9262903
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thoracic soft tissue uptake on a bone scintigraphy. 2 cases].
    Biyi A; Doudouh A; Farik M; Zekri A
    Rev Pneumol Clin; 2006 Sep; 62(4):237-42. PubMed ID: 17075548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incrustation and uptake of skeletal imaging agent in transitional cell carcinoma.
    Taniguchi M; Tatsuta N; Yokota H; Ouguchi M; Higashi K; Okimura T; Yamamoto I
    J Nucl Med; 1997 Aug; 38(8):1206-7. PubMed ID: 9255150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical uptake of 99m Tc-HMDP in a patient with metastatic liver disease.
    Moya Espinosa P; Amrani Raissouni T; Ramos Moreno E; Martínez del Valle Torres MD; Ortega Lozano SJ; Jiménez-Hoyuela García JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):350-1. PubMed ID: 23169390
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary tumor associated with diffuse bilateral lung uptake of bone imaging agent.
    Antar MA; Mack JM; Spencer RP; Crotty JM
    Clin Nucl Med; 1990 Jan; 15(1):46-7. PubMed ID: 2155083
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concentration of 99mTc methylen-diphosphonate in pulmonary small cell anaplastic carcinoma and hepatic metastasis from pulmonary adenocarcinoma. Report of two cases (author's transl)].
    Okimura T; Miyamura T; Yamamoto T; Higashi K; Nishiki M; Hamada S; Miyatani H; Kobayashi M; Tonami H; Takarada A; Yamagishi T; Tani K
    Rinsho Hoshasen; 1982 Jan; 27(1):127-30. PubMed ID: 6281487
    [No Abstract]   [Full Text] [Related]  

  • 18. Postchemotherapeutic reversibility of hypertrophic osteoarthropathy in a patient with bronchogenic adenocarcinoma.
    Albrecht S; Keller A
    Clin Nucl Med; 2003 Jun; 28(6):463-6. PubMed ID: 12911093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extraosseous nuclide uptake during skeletal scintigraphy. Heparin-calcium-induced 99mTc-HMDP accumulation].
    Baum RP; Brandhorst I; Maul FD; Hör G
    Rofo; 1985 Aug; 143(2):247-9. PubMed ID: 2992051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.